What's more, part of that TopExamCollection CIC dumps now are free: https://drive.google.com/open?id=1MeUEWOUjQMiEFUffWaHujsBtupGlKjo9
Wondering where you can find the perfect materials for the exam? Don't leave your fate depending on thick books about the exam. Our authoritative CBIC Certified Infection Control Exam practice materials are licensed products. Whether newbie or experienced exam candidates you will be eager to have them. And they all made huge advancement after using them. So prepare to be amazed by our CIC practice materials. We can absolutely guarantee that even if the first time to take the exam, candidates can pass smoothly.
| Section | Weight | Objectives |
|---|---|---|
| Topic 1: Education, Research, and Quality Improvement | 9% | - Performance measurement and quality improvement - Evidence-based practice and research application - Regulatory and accreditation compliance - Development and delivery of education programs |
| Topic 2: Surveillance and Epidemiologic Investigation | 24% | - Benchmarking and reporting - Surveillance system design and implementation - Outbreak investigation and response - Data collection, validation, and analysis |
| Topic 3: Employee and Occupational Health | 10% | - Workplace safety policies - Immunization programs - Health screening and surveillance - Exposure management and post-exposure prophylaxis |
| Topic 4: Prevention and Control of Transmission of Infectious Agents | 28% | - Antimicrobial stewardship - Hand hygiene and aseptic techniques - Isolation and patient placement - Cleaning, disinfection, and sterilization - Standard and transmission-based precautions |
| Topic 5: Identification of Infectious Disease Processes | 19% | - Epidemiologic principles - Emerging and re-emerging pathogens - Risk factors and transmission mechanisms - Microbiology and pathogenesis |
| Topic 6: Environment of Care | 10% | - Water and air quality management - Waste management and environmental services - Safety and risk assessment - Facility design, construction, and renovation |
In addition to the PDF questions TopExamCollection offers desktop CBIC Certified Infection Control Exam (CIC) practice exam software and web-based CBIC Certified Infection Control Exam (CIC) practice exam, to help you cope with CBIC Certified Infection Control Exam (CIC) exam anxiety. These CBIC CIC Practice Exams simulate the actual CBIC CIC exam conditions and provide you with an accurate assessment of your readiness for the CIC exam.
NEW QUESTION # 156
A 36-year-old female presents to the Emergency Department with a petechial rash, meningitis, and cardiac arrest. During the resuscitation, a phlebotomist sustained a needlestick injury. The next day, blood cultures reveal Neisseria meningitidis. The exposure management for the phlebotomist is:
Answer: D
Explanation:
The scenario involves a needlestick injury sustained by a phlebotomist during the resuscitation of a patient diagnosed with Neisseria meningitidis infection, characterized by a petechial rash, meningitis, and cardiac arrest. Neisseria meningitidis is a gram-negative diplococcus that can cause meningococcal disease, including meningitis and septicemia, and is transmitted through direct contact with respiratory secretions or, in rare cases, blood exposure. The exposure management for the phlebotomist must align with infection control guidelines, such as those from the Certification Board of Infection Control and Epidemiology (CBIC) and the CDC, to prevent potential infection. Let's evaluate each option:
* A. Prophylactic rifampin plus isoniazid: Prophylactic antibiotics are recommended for close contacts of individuals with meningococcal disease to prevent secondary cases. Rifampin is a standard prophylactic agent for Neisseria meningitidis exposure, typically administered as a 2-day course (e.g., 600 mg every
12 hours for adults). Isoniazid, however, is used for tuberculosis (TB) prophylaxis and is not indicated for meningococcal disease. Combining rifampin with isoniazid is incorrect, as it reflects a confusion with TB management rather than meningococcal exposure. This option is not appropriate.
* B. A tuberculin skin test now and in ten weeks: A tuberculin skin test (TST) or interferon-gamma release assay (IGRA) is used to screen for latent tuberculosis infection, with a follow-up test at 8-10 weeks to detect conversion after potential TB exposure. Neisseria meningitidis is not related to TB, and a needlestick injury from a meningococcal patient does not warrant TB testing. This option is irrelevant to the scenario and not the correct exposure management.
* C. Work furlough from day ten to day 21 after exposure: Neisseria meningitidis has an incubation period of 2-10 days, with a maximum of about 14 days in rare cases. The CDC and WHO recommend that healthcare workers exposed to meningococcal disease via needlestick or mucosal exposure be monitored for signs of infection (e.g., fever, rash) and, if symptomatic, isolated and treated.
Additionally, a work restriction or furlough from day 10 to day 21 after exposure is advised to cover the potential incubation period, especially if prophylaxis is declined or contraindicated. This allows time to observe for symptoms and prevents transmission to vulnerable patients. This is a standard infection control measure and the most appropriate initial management step pending prophylaxis decision.
* D. A review of the phlebotomist's hepatitis B vaccine status: Reviewing hepatitis B vaccine status is a critical step following a needlestick injury, as hepatitis B can be transmitted through blood exposure.
However, this applies to bloodborne pathogens (e.g., HBV, HCV, HIV) and is not specific to Neisseria meningitidis, which is primarily a respiratory or mucosal pathogen. While hepatitis B management (e.
g., post-exposure prophylaxis with hepatitis B immunoglobulin or vaccine booster) should be addressed as part of a comprehensive needlestick protocol, it is not the first or most relevant priority for meningococcal exposure.
The best answer is C, as the work furlough from day 10 to day 21 after exposure addresses the specific risk of meningococcal disease following a needlestick injury. This aligns with CBIC's focus on timely intervention and work restriction to prevent transmission in healthcare settings. Prophylactic antibiotics (e.g., rifampin) should also be considered, but the question asks for the exposure management, and furlough is a primary control measure. Hepatitis B and TBconsiderations are secondary and managed separately.
:
CBIC Infection Prevention and Control (IPC) Core Competency Model (updated 2023), Domain III:
Prevention and Control of Infectious Diseases, which includes protocols for managing exposure to communicable diseases like meningococcal infection.
CBIC Examination Content Outline, Domain IV: Environment of Care, which addresses work restrictions and exposure management.
CDC Guidelines for Meningococcal Disease Prevention and Control (2023), which recommend work furlough and monitoring for exposed healthcare workers.
NEW QUESTION # 157
A task force formed to focus on Clostridioides difficile infections (CDIs). The topic of the meeting discussed selecting the correct germicidal wipe. What important factor does the infection preventionist review?
Answer: D
Explanation:
The correct answer is C, "Time the surface remains wet," as this is the most important factor the infection preventionist (IP) should review when selecting a germicidal wipe for controlling Clostridioides difficile infections (CDIs). According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, effective environmental cleaning is a critical component of infection prevention, particularly for pathogens like C. difficile, which forms hardy spores that are resistant to many disinfectants. The efficacy of a germicidal wipe depends on the contact time-the duration the surface must remain wet with the disinfectant to ensure the killing of C. difficile spores. This is specified by the manufacturer and supported by guidelines from the Centers for Disease Control and Prevention (CDC) and the Environmental Protection Agency (EPA), which emphasize that the disinfectant must remain wet on the surface for the full recommended contact time (typically 1-10 minutes for sporicidal agents) to achieve the desired level of disinfection (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.4 - Implement environmental cleaning and disinfection protocols).
Option A (cost of a case of wipes) is a practical consideration for budgeting but is secondary to efficacy in infection control, especially for a high-priority pathogen like C. difficile. Option B (size of individual wipes) may affect coverage and convenience but does not directly impact the wipe's ability to eliminate the pathogen. Option D (correct disposal of the wipe) is important for preventing cross-contamination and ensuring compliance with waste management protocols, but it is a procedural step after use and not the primary factor in selecting the wipe.
The IP's review of contact time aligns with CBIC's focus on evidence-based practices to prevent healthcare- associated infections (HAIs). For C. difficile, which is a leading cause of HAIs, selecting a wipe with an appropriate sporicidal agent and ensuring adequate wet contact time is essential to disrupt transmission, particularly in outbreak settings (CDC Guidelines for Environmental Infection Control in Healthcare Facilities, 2019). This factor directly influences the wipe's effectiveness, making it the critical review point for the task force.
References: CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.4 - Implement environmental cleaning and disinfection protocols. CDC Guidelines for Environmental Infection Control in Healthcare Facilities, 2019.
NEW QUESTION # 158
Which of the following anti-infective materials is used on endotracheal tubes, urine catheters, and intravascular catheters?
Answer: B
Explanation:
The CBIC Certified Infection Control Exam Study Guide (6th edition) identifies silver as an anti-infective material commonly incorporated into medical devices such as endotracheal tubes, urinary catheters, and intravascular catheters. Silver has broad-spectrum antimicrobial properties against bacteria, fungi, and some viruses. When used as a coating or impregnated material, silver ions disrupt microbial cell membranes, interfere with enzyme systems, and inhibit replication-thereby reducing microbial colonization and biofilm formation on device surfaces.
Device-associated infections often originate from colonization of indwelling devices. Silver-coated or silver- impregnated devices are intended to reduce the risk of healthcare-associated infections by limiting early microbial adherence and growth, particularly during the highest-risk period shortly after device insertion.
Examples include silver alloy urinary catheters for CAUTI prevention and silver-coated endotracheal tubes designed to reduce ventilator-associated events.
The other options listed are not used in this context. Copper has antimicrobial properties but is not commonly used in indwelling medical devices. Chromium is used for corrosion resistance in alloys, not for infection prevention. Zinc plays roles in wound care and topical formulations but is not standard for catheter or tube coatings.
For CIC exam preparation, recognizing silver as the anti-infective material used in multiple indwelling devices is important, as it reflects evidence-based strategies aimed at reducing device-associated infection risk.
NEW QUESTION # 159
An infection preventionist is evaluating a new catheter that may decrease the rate of catheter-associated urinary tract infections. Which of the following provides the BEST information to support the selection of this catheter?
Answer: B
Explanation:
The correct answer is D, "Cost benefit analysis and safety considerations," as this provides the best information to support the selection of a new catheter aimed at decreasing the rate of catheter-associated urinary tract infections (CAUTIs). According to the Certification Board of Infection Control and Epidemiology (CBIC) guidelines, selecting medical devices like catheters for infection prevention involves a comprehensive evaluation that balances efficacy, safety, and economic impact. A cost-benefit analysis assesses the financial implications (e.g., reduced infection rates leading to lower treatment costs) against the cost of the new catheter, while safety considerations ensure the device minimizes patient risk, such as reducing biofilm formation or irritation that contributes to CAUTIs (CBIC Practice Analysis, 2022, Domain III: Infection Prevention and Control, Competency 3.3 - Ensure safe reprocessing of medical equipment). This dual focus provides evidence-based data to justify the catheter's adoption, aligning with the goal of improving patient outcomes and reducing healthcare-associated infections (HAIs).
Option A (staff member preference and product availability) is subjective and logistical rather than evidence- based, making it insufficient for a decision that impacts infection rates. Option B (product materials and vendor information) offers technical details but lacks the broader context of efficacy and cost-effectiveness needed for a comprehensive evaluation. Option C (value analysis and information provided by the manufacturer) includes a structured assessment of value, but it may be biased toward the manufacturer's claims and lacks the independent safety and cost-benefit perspective critical for infection prevention decisions.
The emphasis on cost-benefit analysis and safety considerations reflects CBIC's priority on using data-driven and patient-centered approaches to select interventions that enhance infection control (CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.5 - Use data to guide infection prevention and control strategies). This approach ensures the catheter's selection is supported by robust evidence, optimizing both clinical and economic outcomes in the prevention of CAUTIs.
References: CBIC Practice Analysis, 2022, Domain II: Surveillance and Epidemiologic Investigation, Competency 2.5 - Use data to guide infection prevention and control strategies; Domain III: Infection Prevention and Control, Competency 3.3 - Ensure safe reprocessing of medical equipment.
NEW QUESTION # 160
Therapeutic antimicrobial agents should be used when
Answer: C
Explanation:
Therapeutic antimicrobial agentsshould ideally bepathogen-directedto minimizeresistance, side effects, and treatment failure. Once thecausative pathogen and its antimicrobial susceptibilities are known, the mostnarrow-spectrum, effectiveagent should be used.
Why the Other Options Are Incorrect?
* A. The infecting agent is unknown- Empiric therapy may be necessary initially, but definitive therapy should be based on pathogen identification.
* B. The patient's illness warrants treatment prior to culture results- This applies toempiric therapy
, but not todefinitive antimicrobial selection.
* C. The patient's symptoms suggest likely pathogens- Clinical presentation guidesempiric treatment
, butdefinitive therapy should follow culture and susceptibility testing.
CBIC Infection Control Reference
APIC emphasizes theimportance of selecting antimicrobials based on pathogen identification and susceptibility testingto preventantimicrobial resistance.
NEW QUESTION # 161
......
We have authoritative production team made up by thousands of experts helping you get hang of our CIC study question and enjoy the high quality study experience. We will update the content of CIC test guide from time to time according to recent changes of examination outline and current policies. Besides, our CIC Exam Questions can help you optimize your learning method by simplifying obscure concepts so that you can master better. One more to mention, with our CIC test guide, there is no doubt that you can cut down your preparing time in 20-30 hours of practice before you take the exam.
CIC Certification Test Questions: https://www.topexamcollection.com/CIC-vce-collection.html
2026 Latest TopExamCollection CIC PDF Dumps and CIC Exam Engine Free Share: https://drive.google.com/open?id=1MeUEWOUjQMiEFUffWaHujsBtupGlKjo9